【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 11
2 Pharmaceuticals & Healthcare, Global, Deal Summary, Q4 2014 15
2.1 Pharmaceuticals & Healthcare, Global, Deals Analysis, Q4 2014 15
2.2 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, Q4 2014 17
2.3 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, Q4 2014 18
2.4 Pharmaceuticals & Healthcare, Global, Top Deals, Q4 2014 19
2.4.1 Actavis to Acquire Allergan for USD66 Billion 19
2.4.2 Medtronic Raises USD17 Billion in Private Placement of Notes 20
2.4.3 Merck Acquires Cubist Pharma for USD9.5 Billion 20
2.4.4 Bayer Raises USD7 Billion in Public Offering Bonds 21
2.4.5 LabCorp to Acquire Covance for USD6.1 Billion 21
3 Pharmaceuticals & Healthcare, Global, Deals Summary, by Type 23
3.1 Pharmaceuticals & Healthcare, Global, M&A, Q4 2014 23
3.1.1 Top M&A Deals in Q4 2014 24
3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals, by Therapy Area, Q4 2013 – Q4 2014 25
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Q4 2014 26
3.2.1 Top Initial Public Offerings in Q4 2014 27
3.2.2 Top Secondary Offerings in Q4 2014 28
3.2.3 Top PIPE Deals in Q4 2014 28
3.2.4 Pharmaceuticals & Healthcare, Global, Top IPOs Share Performance, Q4 2013-Q4 2014 29
3.2.5 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, by Therapy Area, Q4 2013 – Q4 2014 29
3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, Q4 2014 31
3.3.1 Top Venture Financing Deals in Q4 2014 32
3.3.2 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Q4 2014 33
3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Q4 2014 34
3.3.4 Pharmaceuticals & Healthcare, Global, Venture Capital, by Therapy Area, Q4 2013 – Q4 2014 35
3.3.5 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, Q4 2013 – Q4 2014 36
3.3.6 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, Q4 2013 – Q4 2014 37
3.4 Pharmaceuticals & Healthcare, Global, Private Equity Deals, Q4 2014 38
3.4.1 Top Private Equity Deals in Q4 2014 39
3.4.2 Pharmaceuticals & Healthcare, Global, Private Equity Deals, by Therapy Area, Q4 2013 – Q4 2014 40
4 Pharmaceuticals & Healthcare, Global, Partnership Deals, Q4 2014 42
4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, Q4 2014 42
4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Q4 2013 – Q4 2014 44
4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Upfront & Milestone Payments and Deal Values (US$ m), Q4 2014 46
4.3.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Deal Values, Q4 2014 47
4.3.2 Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Upfront Payment, Q4 2014 48
4.3.3 Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Milestone Payments, Q4 2014 48
4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, by Upfront & Milestone Payments and Deal Values (US$ m), Q4 2013 – Q4 2014 49
4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Number Of Deals, Q4 2013 – Q4 2014 51
4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Deal Values (US$ m), Q4 2013 – Q4 2014 52
4.7 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), Q4 2013 – Q4 2014 53
5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, Q4 2014 55
5.1 Pharmaceutical & Healthcare, Global, Licensing Agreements, Q4 2014 55
5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront & Milestone Payments and Deal Values (US$ m), Q4 2013 – Q4 2014 57
5.2.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Deal Value, Q4 2014 58
5.2.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, Q4 2014 59
5.2.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Milestone Payment, Q4 2014 60
5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Therapy Area, Total Deal Value (US$ m), Q4 2013 – Q4 2014 61
5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Therapy Area, Upfront Payments Vs Milestone Payments (US$ m), Q4 2013 – Q4 2014 63
5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Total Deal Values (US$ m), Q4 2013 – Q4 2014 65
5.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Total Deal Values (US$ m), Q4 2013 – Q4 2014 66
5.7 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Upfront Payments Vs Milestone Payments (US$ m), Q4 2013 – Q4 2014 68
6 Pharmaceuticals & Healthcare, Global, M&A Financial Analysis 70
6.1 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value versus Median Deal Value, Q4 2013 – Q4 2014 70
6.2 Pharmaceuticals& Healthcare, Global Acquisitions, Average Price Earnings of Acquired Companies, Q4 2013 – Q4 2014 72
6.3 Pharmaceuticals & Healthcare, Global Acquisitions, Average EV/EBITDA of Acquired Companies, Q4 2013 – Q4 2014 73
6.4 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value per Operating Profit, Q4 2013 – Q4 2014 75
6.5 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value Per Share versus Average Market Price Per Share, Q4 2013 – Q4 2014 77
6.6 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value Per Share versus Average Book Value Per Share, Q4 2013 – Q4 2014 78
6.7 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value Per Sales, Q4 2013 – Q4 2014 79
7 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area 80
7.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, Q4 2014 80
7.1.1 Oncology – Deals of the Quarter 82
7.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, Q4 2014 84
7.2.1 Central Nervous System – Deals of the Quarter 86
7.3 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, Q4 2014 88
7.3.1 Infectious Disease – Deals of the Quarter 89
7.4 Pharmaceuticals & Healthcare, Global, Immunology Deals, Q4 2014 92
7.4.1 Immunology – Deals of the Quarter 94
7.5 Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals, Q4 2014 96
7.5.1 Metabolic Disorders – Deals of the Quarter 97
7.6 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, Q4 2014 100
7.6.1 Cardiovascular – Deals of the Quarter 101
7.7 Pharmaceuticals & Healthcare, Global, Gastrointestinal Deals, Q4 2014 103
7.7.1 Gastrointestinal – Deals of the Quarter 104
7.8 Pharmaceuticals & Healthcare, Global, Dermatology Deals, Q4 2014 106
7.8.1 Dermatology – Deals of the Quarter 107
7.9 Pharmaceuticals & Healthcare, Global, Respiratory Deals, Q4 2014 109
7.9.1 Respiratory – Deals of the Quarter 110
7.10 Pharmaceuticals & Healthcare, Global, Ophthalmology Deals, Q4 2014 113
7.10.1 Ophthalmology – Deals of the Quarter 114
8 Deal Summary by Geography 117
8.1 Pharmaceuticals & Healthcare, North America Region, Deals, Q4 2014 117
8.1.1 North America – Deals of the Quarter 119
8.2 Pharmaceuticals & Healthcare, Europe Region, Deals, Q4 2014 121
8.2.1 Europe – Deals of the Quarter 122
8.3 Pharmaceuticals & Healthcare, Asia-Pacific, Deals, Q4 2014 126
8.3.1 Asia-Pacific – Deals of the Quarter 127
8.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, Q4 2014 129
8.4.1 Rest of the World – Deals of the Quarter 130
9 Pharmaceuticals & Healthcare, Global, Top Advisors 132
9.1 Pharmaceuticals & Healthcare, Global Top Financial Advisors, M&A, Q4 2013 – Q4 2014 132
9.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, Q4 2013 – Q4 2014 134
10 Appendix 136
11 Further Information 139
11.1 Methodology 139
11.2 About GlobalData 140
11.3 Disclosure information 141
11.4 Disclaimer 141
【レポート販売概要】
■ タイトル：世界の製薬産業における事業提携、ライセンス、投資、M&A動向（2014年第4四半期版）■ 英文：Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q4 2014
■ 発行日：2015年2月15日
■ 調査会社：GlobalData
■ 商品コード：GDPH0473QD
■ 調査対象地域：グローバル
- 世界のRFデュプレクサ市場2015The Global RF Duplexer Industry 2015 Market Research Report is a professional and in-depth study on the current state of the RF Duplexer industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The RF Duplexer market analysis is provided for the international markets including development trends, competitive la …
- 医療用エクソスケルトンの世界市場：コンポーネント別（ソフトウェア、ハードウェア）、タイプ別（パッシブ、電動）、四肢部位別（下肢、上肢）、モビリティ別（可動、定置）、地域別予測Global Medical Exoskeleton Market to reach USD 1.03 billion by 2025. Global Medical Exoskeleton Market valued approximately USD 64 million in 2016 is forecasted to grow with a healthy growth rate of more than 36.2% over the forecast period 2018-2025. The major factors speculated to augment the markets are rising insurance coverage for medical exoskeletons and rising number of people with physical …
- ヒドロタルシトの世界市場Hydrotalcite (CAS 12304-65-3) Market Research Report 2013 presents comprehensive data on hydrotalcite markets globally and regionally (Europe, Asia, North America etc.) The Hydrotalcite (CAS 12304-65-3) Market Research Report 2013 includes hydrotalcite description, covers its application areas and related patterns. It overviews hydrotalcite market, names hydrotalcite producers and indicates its su …
- サスペンション（懸架装置）の世界市場予測（～2021）The suspension system market size is projected to grow at a CAGR of 5.11% during the forecast period, to reach USD 67.22 Billion by 2021. Increasing demand for riding comfort, stability, better cornering, safety, luxury, technological advancements, along with stringent emission regulations and fuel efficiency standards enforced by the different legislative bodies across the globe are driving the s …
- SDカードの世界市場2016-2020About Secure Digital Card SD cards are data storage devices used for storing digital information. These cards have non-volatile memory chips that can be reprogrammed multiple times during their life span. Their compact physical size and high storage capabilities with reprogrammable features have increased the penetration of SD cards in the digital world. Different standards for SD cards came into …
- 自動車インタークーラーの世界市場2015-2019The growth of automotive intercoolers is directly impacted by developments in the turbocharger market as intercoolers play a vital role in cooling compressed air. Technavios market research analysts predict the global automotive intercooler market to grow at a CAGR of over 9% from 2015 to 2019. Intercoolers reduce the air temperature and increase the engine's output and performance. These componen …
- イギリスの高圧コンデンサ市場：主要用途、ドライバー、トレンドHigh Voltage Capacitors in the UK: Key Applications, Drivers and Emerging Trends Summary With the sharp increase in investment in distributed intermittent generators and High Voltage (HV) power consuming industrial facilities along with the need for ultra-HV lines; shunt reactors and series capacitors have become essential electrical equipment for the management of global power systems. There has …
- 世界の質量分析市場動向及び予測（～2018）Over the years, the mass spectrometry market—comprising of instruments, consumables, and services—has witnessed various technological advancements. These advancements have led to a growth in the number of mass spectrometry applications. Some of the applications using mass spectrometry are drug discovery and development, metabolomics, biomarkers, and diagnostics. However, the high cost of instrumen …
- 世界のスマート照明市場機会分析In the past 18 months, the smart lighting business has taken important new directions, creating opportunities at every level of the lighting value chain. As NanoMarkets has predicted for several years now, smart lighting vendors now see their value proposition as having more to do with mood lighting than lighting efficiency. In addition, smart lighting is now conceived of as part of the Internet-o …
- シランの世界市場2018-2022112 pages, November 2018 About this market The market has undergone rapid consolidation due to increased merger and acquisitions in the market. This has resulted in the presence of more competent and technology- driven players in the market. Therefore, the growing number of mergers and acquisitions is expected to further consolidate the global silanes market during the forecast market. The promine …
- トルコのICT市場：通信、ハードウェア、ソフトウェア、ITサービスAbout ICT ICT is an integrated platform comprising communication devices or applications, computer and network hardware, software, and services. It helps organizations store, safeguard, transmit, and retrieve information. Many countries have established various systems to develop and promote ICT across industry verticals. Increased advances in technology have bridged the gap between available reso …
- アメリカの不妊治療市場2016-2020About Fertility Couples with fertility issues are unable to conceive even after regular unprotected coitus (six months if the woman is over age 35). Female or male infertility factors account for one-third of the cases, where a couple is unable to conceive. In the rest of the cases, the cause is either unknown or a combination of both male and female infertility factors. In males, low sperm produc …
- 建築用レンダーソフトの世界市場2016-2020About Architectural Rendering Software Rendering is the graphical process of creating a visual scene through computer-generated light waves. It creates the visualization of 3D objects based on the strength of light waves or particles that are created by the rendering software itself. Virtualization software is used to develop a real animation world around 3D objects that are created by the renderi …
- 脂肪酸メチルエステルスルホネート（FMES）の世界市場分析：エンドユーザー別（パーソナルケア、洗剤）、地域別（北アメリカ、ヨーロッパ、アジア太平洋、中南米、中東、アフリカ）、競争戦略、セグメント予測The global fatty methyl ester sulfonate (FMES) market is expected to reach USD 2.49 billion by 2025, according to a new report by Grand View Research, Inc. Rising consumer awareness towards cleanliness, hygiene, and health is anticipated to be a major factor for significant market growth for FMES based personal care over the next few years. Growing population coupled with increasing disposable con …
- 世界のジメトエート市場2015The Global Dimethoate Industry Report 2015 is a professional and in-depth study on the current state of the Dimethoate industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Dimethoate market analysis is provided for the international markets including development trends, competitive landscape analysis, a …
